Literature DB >> 9149572

The usefulness of diagnostic tests on pericardial fluid.

D G Meyers1, R E Meyers, T W Prendergast.   

Abstract

STUDY
OBJECTIVES: To determine the physical, chemical, and cellular characteristics of pericardial fluid in various disease states and to assess their diagnostic accuracies.
SETTING: A metropolitan university hospital.
DESIGN: Consecutive case series. PATIENTS: One hundred seventy-five hospital patients, aged 1 month to 87 years, who had undergone pericardiocentesis (n = 165) or control subjects who had undergone open heart surgery (n = 10) between 1984 and 1996. MEASUREMENTS: The appearance of pericardial fluid and results of chemistry tests, cell counts, cytologic studies, Gram's stain, and microbial cultures were obtained by chart review. The etiology of each pericardial fluid sample was determined using prospective diagnostic criteria.
RESULTS: Exudates differed from transudates by higher leukocyte counts and ratios of fluid to serum lactate dehydrogenase levels. Fluid glucose levels were significantly less in exudates. Sensitivity for detecting exudates was high for specific gravity > 1.015 (90%), fluid total protein > 3.0 g/dL (97%), fluid to serum protein ratio > 0.5 (96%), fluid lactate dehydrogenase ratio > 0.6 (94%), and fluid to serum glucose ratio < 1.0 (85%). None of these indicators were specific. Fluid total protein and specific gravity were moderately correlated (r = 0.56). Fluid cytologic study had a sensitivity of 92% and specificity of 100% for malignant effusion. No other test was diagnostic for a specific etiology. Among infection-associated effusions, culture-positive fluid had more neutrophils, higher lactate dehydrogenase levels, and lower ratios of fluid to serum glucose than culture-negative (parainfective) fluid.
CONCLUSIONS: Evaluation of pericardial fluid might be limited to cell count, glucose, protein, and lactate dehydrogenase determinations plus bacterial culture and cytology. While not used routinely, other tests that may be highly specific for particular diseases should be ordered only to confirm a high clinical suspicion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9149572     DOI: 10.1378/chest.111.5.1213

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  28 in total

Review 1.  Practical aspects of the management of pericardial disease.

Authors:  Bernhard Maisch; Arsen D Ristić
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

2.  [Tumor markers in the assessment of malignant and benign pericardial effusion].

Authors:  K Karatolios; B Maisch; S Pankuweit
Journal:  Herz       Date:  2011-06       Impact factor: 1.443

3.  Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution.

Authors:  Kie Kasuga; Rong Yang; Timothy F Porter; Nitin Agrawal; Nicos A Petasis; Daniel Irimia; Mehmet Toner; Charles N Serhan
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

4.  Cytopathology of pericardial effusions : Experience from a tertiary center of cardiology.

Authors:  C Gecmen; G G Gecmen; D Ece; M Kahyaoğlu; A Kalayci; C Y Karabay; O Candan; M E Isik; F Yilmaz; O Akgun; M Celik; I A Izgi; C Kirma; S Keser
Journal:  Herz       Date:  2017-07-10       Impact factor: 1.443

Review 5.  The classification of pericardial disease in the age of modern medicine.

Authors:  Bernhard Maisch; Arsen D Ristić
Journal:  Curr Cardiol Rep       Date:  2002-01       Impact factor: 2.931

Review 6.  Neoplastic pericardial effusion.

Authors:  Marwan M Refaat; William E Katz
Journal:  Clin Cardiol       Date:  2011-09-16       Impact factor: 2.882

7.  Pericardiocentesis versus pericardiotomy for malignant pericardial effusion: a retrospective comparison.

Authors:  C Labbé; L Tremblay; Y Lacasse
Journal:  Curr Oncol       Date:  2015-12       Impact factor: 3.677

8.  [Differentiation of malignant from nonmalignant, inflammatory pericardial effusions with biomarkers].

Authors:  Konstantinos Karatolios; Peter Alter; Bernhard Maisch
Journal:  Herz       Date:  2009-12       Impact factor: 1.443

9.  Pericardioscopy and epi- and pericardial biopsy - a new window to the heart improving etiological diagnoses and permitting targeted intrapericardial therapy.

Authors:  Bernhard Maisch; Heinz Rupp; Arsen Ristic; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

Review 10.  [New possibilities of diagnostics and therapy of pericarditis].

Authors:  B Maisch; K Karatolios
Journal:  Internist (Berl)       Date:  2008-01       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.